Search results
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 1 day agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said ...
Jump Financial LLC Has $369,000 Stock Position in Acelyrin, Inc. (NASDAQ:SLRN)
ETF DAILY NEWS· 6 hours agoJump Financial LLC lifted its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 152.7% during the fourth quarter, according to the company in its most recent filing with the Securities ...
Elizabeth Mellins
Denver Post· 6 days agoMellins, professor of pediatrics at the Stanford University School of Medicine, was a groundbreaking pediatric rheumatologist and immunologist whose...
Research shows linked biological pathways driving skin inflammation
Medical Xpress· 5 days agoInflammation is the body's natural response to irritation and infection, but when out of control, it...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 9 hours agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 2 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 1 day agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 5 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...